The new Amass app is live. Ask in plain language, check every claim. Try it free

Skills & PromptsTrial evidence trace

Skill

Trial evidence trace

Paste one clinical-trial ID; get the exact published papers that describe it — pulled from Amass's publication↔trial graph, with trust metadata and abstract-grounded relevance notes.

New to Amass? Connect Amass to Claude first

7linked papers
2trials traced
You getcsv2 files
Skillclinical-evidenceclaude

The prompt

Paste this into Claude

Clinical-trial ID (NCT or AMTC)NCT04611802
prompt
Use the Trial evidence trace skill.

Clinical-trial ID (NCT or AMTC): NCT04611802

Why not just ask the model?

Ask a plain model "which papers describe NCT04611802?" and it invents plausible citations and PMIDs, because it has no real trial→paper map to read from.

  • Plain model: fabricates titles, PMIDs, and journals that "sound like" the trial's literature, and conflates papers that merely cite COVID-vaccine work with the ones that actually report this trial.
  • Amass: the trial record carries a first-class referencesBiomedCore edge — the Amass IDs of the publications that describe it. Each fetched paper returns its verbatim title, journal, publicationDate, citationCount, journalQualityJufo, and isRetracted, with a relevance note quoted straight from the returned abstract. Nothing is guessed.

Why a skill, not a prompt?

This is a multi-step orchestration, not a one-shot lookup: one get_amass_trialcore_record reads the trial's referencesBiomedCore array, then a get_amass_biomedcore_record by-id fan-out runs once per referenced paper to pull its trust metadata and abstract, then a templated roll-up sorts by citation count and emits the CSV. Packaging it as a skill means the rate-limit-batched fan-out — and the metadata-only recovery for trials whose landmark papers overflow the per-call token budget — ships once and triggers with a single line, instead of re-pasting a brittle procedure every time.

Honest scope

The describing-paper count is the trial's referencesBiomedCore length (7 for PREVENT-19), not an exhaustive literature search — broaden coverage by also searching BiomedCore for the trial's acronym and unioning the results. Citation counts and trust metadata are verbatim from Amass and can lag the source databases by hours. Every relevance note is grounded in the paper's own abstract; where the abstract is silent it reads "not in abstract", and no trial-outcome string is paraphrased from a field the MCP does not expose (it does not surface primaryOutcomeMeasures).

Install the skill

Add the skill to Claude

Install every Amass skill with one command, npx skills add amass-technologies/public-skills or download the SKILL.md from GitHub and add it to Claude (Settings → Capabilities → Skills, or drop it in your Claude Code skills directory). Then paste the prompt above to trigger it.

More from the library

Keep exploring

xlsx
14trials watched
Short nameSource idRegistryCopy of
Acute, 50/75 mg vs placeboNCT04072354ClinicalTrials.gov
↳ EUCTR2019-000470-36-BGEU CTRNCT04072354
Acute, 75/100 mg vs placeboNCT04092686ClinicalTrials.gov
competitive-intelligenceSkill

Watchlist Monitor

Name the trials, papers, approvals or drugs you need to follow; get one Excel board that re-reads them through Amass at every check and tells you exactly what changed: status, dates, enrollment, results posted, label revisions, retractions, new links.

pdf+1
196trials in scope
Landscape Monitor — page 1
competitive-intelligenceSkill

Landscape Monitor

Name a field; get it mapped across trials, papers, patents, drugs, genes and approvals into a landscape page with charts, a workbook and a one-page briefing, every record screened with its reason. Ask for an update later to see what is new and what changed.

csv
12targets scored
kinasekinase_family_chembl_leafsmall_molecule_tractabilityprotac_tractability
PLK1Other protein kinase PLK familyAdvanced Clinicalpredictive-only
WEE1Other protein kinase WEE familyAdvanced Clinicalpredictive-only
CDK1CMGC protein kinase CDK5 subfamilyAdvanced Clinicalpredictive-only
researchSkill

Target prioritization matrix

A general, interview-driven target-discovery workbench: name the biology and the modality you care about, and get back a scored table of candidate targets — druggability, essentiality, genetic constraint, curated safety, and the real number of drugs already targeting each — assembled from GeneCore intelligence and DrugCore/TrialCore/BiomedCore/PatentCore cross-links.

Run it yourself

Connect Amass to Claude and paste the prompt.

The connector takes about a minute to add, then this workflow runs on your own inputs.

Data
No training on your data
Hosting
EU-hosted, enterprise
Isolation
Tenant-isolated by architecture
Certification
ISO 27001, SOC 2, NIS2: in motion